Life, Volume 15, Issue 8
2025 August - 178 articles
Cover Story: Type 2 diabetes (T2D) is a common metabolic disorder marked by chronic hyperglycemia, hyperinsulinemia, and cardiovascular complications. A key feature is disrupted hormone balance—elevated insulin and leptin with reduced adiponectin—which critically shapes immune cell function. T2D patients show a skewed immune profile with increased pro-inflammatory cytokines such as IFN-γ, TNF-α, IL-17, and IL-6, known drivers of vascular inflammation. In addition, altered metabolic hormones foster a pro-inflammatory immune phenotype, indicating that these hormones act not only in energy regulation but also as immune activators. Their dysregulation likely plays an important, and often underrecognized, role in the development of diabetic cardiovascular disease. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.